Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.
Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...
MedPage Today on MSN12d
First Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
Mankind Pharma has launched generic versions of diabetes medication Empagliflozin under brand names Empaglyde, Empagreat, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback